6018.0: Thursday, October 25, 2001 - 8:50 AM

Abstract #25374

Preventable invasive pneumococcal disease and missed opportunities to immunize in hospital

Florencia Pereyra, MD1, Glenn Eiger, MD, FACP1, James W. Sweeney, BSN, RN2, and Barbara Watson, MD3. (1) Department of Medicine, Albert Einstein Medical Center, 5401 Old York Road, Suite 363, Philadelphia, PA 19141, 215-456-4940, pereyraf@aehn2.einstein.edu, (2) Division of Disease Control, Philadelphia Department of Public Health, 500 South Broad Street, Philadelphia, PA 19146, (3) Divison of Disease Control, Philadelphia Department of Public Health, 500 S. Broad Street, Philadelphia, PA 19146

KEYWORDS: Disease Prevention, Immunizations

BACKGROUND Pneumococcal disease accounts for more deaths than any other vaccine preventable bacterial disease. Despite availability of vaccines, patients hospitalized with conditions for which pneumococcal vaccines are indicated are not routinely vaccinated.

OBJECTIVE: To determine the incidence of invasive pneumococcal disease at Albert Einstein Medical Center, and evaluate the documentation and use of vaccine over a three-year period.

METHODS: Patients with invasive pneumococcal disease admitted between September 1, 1997 and September 30, 2000 were identified by a hospital computer database. Microbiology records were reviewed for identification of Streptococcus pneumoniae isolates from sterile sites. Inpatient vaccine administration within 5 years was obtained from the main pharmacy database. Data were analyzed using SPSS statistical software.

RESULTS: A total of 70 patients with a mean age of 54 years (range 19 to 94) had invasive pneumococcal infections and 66% (46/70) had at least one previous hospitalization within 5 years; none had received pneumococcal vaccine during previous hospitalization. Of these 70 patients, vaccine was recommended for only 24% (17/70) with 65% (11/17) receiving vaccine prior to discharge.

CONCLUSIONS: Current strategies used to assess and administer pneumococcal vaccine are inadequate in this institutional setting.

LEARNING OBJECTIVES:

1. To describe the incidence of invasive pneumococcal disease in a hospital setting over a three-year period. 2. To describe pneumococcal vaccine assessment and immunization practices in a hospital setting over a three-year period. 3. Develop an awareness of missed opportunities to assess and vaccinate patients for invasive pneumococcal disease in a hospital setting.

See www.nationalpneumonia.org

Learning Objectives: 1. To describe the incidence of invasive pneumococcal disease in a hospital setting over a three-year period. 2. To describe pneumococcal vaccine assessment and immunization practices in a hospital setting over a three-year period. 3. Develop an awareness of missed opportunities to assess and vaccinate patients for invasive pneumococcal disease in a hospital setting.

Keywords: Disease Prevention, Immunizations

Presenting author's disclosure statement:
Organization/institution whose products or services will be discussed: None
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.

The 129th Annual Meeting of APHA